Prospective Randomized Evaluation of Implantable Cardioverter‐Defibrillator Programming in Patients With a Left Ventricular Assist Device
暂无分享,去创建一个
Christopher R. Ellis | J. Lindenfeld | A. Shah | M. Keebler | K. Schlendorf | Meng Xu | M. Danter | T. Richardson | Ashish S. Shah | L. Hale | C. Arteaga
[1] V. Kutyifa. Is there a need for an implantable cardioverter defibrillator in patients with left ventricular assist devices? Time for MADIT-VAD! , 2017, Expert review of medical devices.
[2] R. Kociol. Time for MADIT-VAD?: ICDs Among LVAD Patients. , 2016, JACC. Heart failure.
[3] I. Anand,et al. Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. , 2016, JACC. Heart failure.
[4] S. Cha,et al. Effect of Continued Cardiac Resynchronization Therapy on Ventricular Arrhythmias After Left Ventricular Assist Device Implantation. , 2016, The American journal of cardiology.
[5] N. Kman,et al. Clinical Communications : Adults ASYMPTOMATIC SUSTAINED POLYMORPHIC VENTRICULAR TACHYCARDIA IN A PATIENT WITH A LEFT VENTRICULAR ASSIST DEVICE : CASE REPORT AND WHAT THE EMERGENCY PHYSICIAN SHOULD KNOW , 2022 .
[6] F. Sacher,et al. Management of Ventricular Arrhythmias in Patients with Mechanical Ventricular Support Devices , 2015, Current Cardiology Reports.
[7] M. Slaughter,et al. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices. , 2015, Journal of cardiac failure.
[8] W. Saliba,et al. Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study). , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] Marc A Miller,et al. The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices , 2013, Circulation. Arrhythmia and electrophysiology.
[10] N. Uriel,et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? , 2013, Journal of the American College of Cardiology.
[11] Nader Moazami,et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[12] Mark A Hlatky,et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.
[13] Paul J. Wang,et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.
[14] L. Allen,et al. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[15] N. Smedira,et al. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. , 2010, Heart rhythm.
[16] Claudia Stöllberger,et al. Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.
[17] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[18] J. Towbin,et al. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[19] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[20] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[21] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[22] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[23] M. Oz,et al. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. , 1994, Journal of the American College of Cardiology.
[24] N Engl,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.